Close Menu

NEW YORK – Ares Genetics, a Curetis Group company, will collaborate with BGI Group to make molecular tests for coronavirus 2019-nCoV available in Europe.

Ares will launch a next-generation sequencing testing service for the virus using BGI reagents. The firm will also collaborate, along with Curetis and BGI, in the distribution of NGS and PCR testing kits.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.